ArticleAdvances in therapy2025

Real-World Utilization of Biologic and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs in Psoriatic Arthritis and Axial Spondyloarthritis: Insights from Sweden and Germany.

Helena Roque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.